NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-036-2022-0-IL-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS IL National Stage 315863 Pending
NIDDK E-067-2022-1-US-01 A3 ADENOSINE RECEPTOR POSITIVE ALLOSTERIC MODULATORS US National Stage 18/850,144 Pending
NIAID E-073-2022-0-US-02 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US National Stage 18/849,734 Pending
NHLBI E-036-2022-0-CA-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS CA National Stage 3246616 Pending
NCI E-138-2023-0-PC-01 A MOLECULAR SCAFFOLD FOR DEPLETING HRPN13 AND A SELECT GROUP OF KEN BOX PROTEINS PCT PCT PCT/US2024/047709 Pending
CC E-241-2023-0-PCT-01 GAIT ASSISTANCE SYSTEMS AND METHODS OF CONTROL THEREOF PCT PCT PCT/US2024/047743 Pending
NCATS E-042-2022-0-JP-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS JP National Stage 2024-556537 Pending
NIDA E-053-2016-2-AU-09 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF AU DIV 2024219951 Pending
NIAID E-080-2022-0-AU-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE AU National Stage 2023241824 Pending
NIAID E-080-2022-0-US-02 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE US National Stage 18/848,883 Pending
NCATS E-042-2022-0-IN-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS IN National Stage 202417070948 Pending
NHLBI E-087-2020-0-PC-01 HERV-E ANTIBODIES AND METHODS OF THEIR USE PCT PCT PCT/US2024/047278 Pending
NIAID E-219-2023-0-PC-01 Stabilized SARS-CoV-2 S Antigens PCT PCT PCT/US2024/046623 Pending
NLM E-023-2023-0-US-02 MODIFICATION-DEPENDENT ENRICHMENT OF DNA BY GENOME OF ORIGIN US National Stage 18/847,077 Pending
NIAAA E-189-2021-0-US-02 CANNABINOID RECEPTOR MODULATING COMPOUNDS US National Stage 18/846,457 Pending
NHLBI E-127-2021-2-HK-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES HK EP 62024096678.3 Pending
NHLBI E-035-2022-0-CN-01 PREPARATION OF ISOTOPICALLY LABELED KETOGLUTARATES AND METHODS OF HYPERPOLARIZATION THROUGH SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE (SABRE) CN National Stage 202380026889.8 Pending
NCI E-075-2022-0-US-02 ANTIBODY MATERIALS AND METHODS TARGETING MICROBIAL POLYSACCHARIDES US National Stage 18/846,077 Pending
NIAID E-080-2022-0-IN-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE IN National Stage 202417068296 Pending
NINDS E-113-2022-1-EP-01 RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2 EP National Stage 23726799.2 Pending
NIAID E-102-2022-0-PC-01 HUMAN PARAINFLUENZA VIRUS IMMUNOGENIC MOLECULES PCT PCT PCT/US2024/045542 Pending
NIAID E-047-2022-0-EP-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses EP National Stage 23708657.4 Pending
NIAID E-047-2022-0-ID-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses ID National Stage P00202408774 Pending
NIAID E-047-2022-0-IN-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses IN National Stage 202417065979 Pending
NIAID E-047-2022-0-AU-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses AU National Stage 2023219176 Pending
NCI E-046-2022-0-CN-01 T CELL THERAPY WITH VACCINATION AS A COMBINATION IMMUNOTHERAPY
AGAINST CANCER 		CN National Stage 202280092973.5 Pending
NHGRI E-100-2017-0-US-02 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS US CON 18/816,498 Pending
NCI E-040-2012-0-AU-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2024216293 Pending
NIAID E-001-2024-1-PC-01 Viral Strain Serology Assays PCT PCT PCT/US2024/043635 Pending
NCATS E-218-2021-0-EP-01 FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF EP National Stage 23709497.4 Pending
NIDA E-053-2016-2-US-08 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF US CON 18/812,693 Pending
NCI E-028-2015-1-CN-01 Anti-Mutated Kras T Cell Receptors CN DIV 202411133523.3 Pending
NCI E-237-2017-2-CN-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 CN DIV 202411117183.5 Pending
NCI E-025-2022-0-EP-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF EP National Stage 23710624.0 Pending
NIAID E-047-2022-0-MX-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses MX National Stage MX/a/2024/009860 Pending
NIAID E-047-2022-0-JP-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses JP National Stage 2024-547536 Pending
NCI E-025-2022-0-JP-01 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF JP National Stage 2024-547534 Pending
NCI E-025-2022-0-US-02 CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF US National Stage 18/837,367 Pending
NIAID E-018-2018-0-US-02 CHIMERIC VECTORS US CON 18/799,179 Pending
NCI E-169-2024-0-PC-01 LNA GAPMERS INHIBIT GROWTH OF CCK-BR POSITIVE CANCER PCT PCT PCT/US2024/041812 Pending
NCATS E-218-2021-0-CA-01 FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF CA National Stage 3243968 Pending
NIAID E-047-2022-0-AE-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses AE National Stage P2024-02085 Pending
NIAID E-047-2022-0-QA-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses QA National Stage QA/202408/00619 Pending
NIAID E-047-2022-0-SA-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses SA National Stage 1120244388 Pending
NIAID E-047-2022-0-ZA-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses ZA National Stage 2024/06123 Pending
NIAID E-047-2022-0-PH-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses PH National Stage 1-2024-551911 Pending
NCATS E-218-2021-0-US-02 SMALL MOLECULE AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF US National Stage 18/837,100 Pending
NCI E-045-2022-0-EP-01 Method of HLA loss Heterozygosity Detection in Liquid Biopsies EP National Stage 23705845.8 Pending
NCI E-158-2023-0-PC-01 POLYFLUORINATED THALIDOMIDE ANALOGS AND USES THEREOF PCT PCT PCT/US2024/041504 Pending
NIAID E-047-2022-0-NG-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses NG National Stage F/PT/PCT/2024/13748 Pending